Logo image of RERE

ATRENEW INC (RERE) Stock Fundamental Analysis

USA - NYSE:RERE - US00138L1089 - ADR

4.575 USD
-0.1 (-2.24%)
Last: 9/25/2025, 11:21:09 AM
Fundamental Rating

5

Overall RERE gets a fundamental rating of 5 out of 10. We evaluated RERE against 122 industry peers in the Specialty Retail industry. No worries on liquidiy or solvency for RERE as it has an excellent financial health rating, but there are worries on the profitability. RERE is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year RERE was profitable.
RERE had negative earnings in each of the past 5 years.
In multiple years RERE reported negative operating cash flow during the last 5 years.
RERE Yearly Net Income VS EBIT VS OCF VS FCFRERE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

The Return On Assets of RERE (2.37%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 3.39%, RERE is in the better half of the industry, outperforming 60.66% of the companies in the same industry.
RERE has a Return On Invested Capital (3.00%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 2.37%
ROE 3.39%
ROIC 3%
ROA(3y)-17.29%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
RERE Yearly ROA, ROE, ROICRERE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

RERE has a Profit Margin (0.73%) which is in line with its industry peers.
RERE has a Operating Margin (0.84%) which is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 11.97%, RERE is doing worse than 89.34% of the companies in the same industry.
RERE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.84%
PM (TTM) 0.73%
GM 11.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y35.7%
RERE Yearly Profit, Operating, Gross MarginsRERE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RERE is destroying value.
The number of shares outstanding for RERE has been reduced compared to 1 year ago.
RERE has about the same amout of shares outstanding than it did 5 years ago.
RERE has a better debt/assets ratio than last year.
RERE Yearly Shares OutstandingRERE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RERE Yearly Total Debt VS Total AssetsRERE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

RERE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.36
WACC8.38%
RERE Yearly LT Debt VS Equity VS FCFRERE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

RERE has a Current Ratio of 2.92. This indicates that RERE is financially healthy and has no problem in meeting its short term obligations.
RERE's Current ratio of 2.92 is amongst the best of the industry. RERE outperforms 91.80% of its industry peers.
A Quick Ratio of 2.44 indicates that RERE has no problem at all paying its short term obligations.
The Quick ratio of RERE (2.44) is better than 94.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.44
RERE Yearly Current Assets VS Current LiabilitesRERE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 164.02% over the past year.
Looking at the last year, RERE shows a very strong growth in Revenue. The Revenue has grown by 26.08%.
The Revenue has been growing by 32.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)164.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%269.23%
Revenue 1Y (TTM)26.08%
Revenue growth 3Y28.03%
Revenue growth 5Y32.94%
Sales Q2Q%27.45%

3.2 Future

RERE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 372.58% yearly.
The Revenue is expected to grow by 26.79% on average over the next years. This is a very strong growth
EPS Next Y1288.89%
EPS Next 2Y372.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.47%
Revenue Next 2Y26.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
RERE Yearly Revenue VS EstimatesRERE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B 15B 20B 25B
RERE Yearly EPS VS EstimatesRERE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 57.19 indicates a quite expensive valuation of RERE.
The rest of the industry has a similar Price/Earnings ratio as RERE.
When comparing the Price/Earnings ratio of RERE to the average of the S&P500 Index (27.29), we can say RERE is valued expensively.
The Price/Forward Earnings ratio is 7.95, which indicates a rather cheap valuation of RERE.
91.80% of the companies in the same industry are more expensive than RERE, based on the Price/Forward Earnings ratio.
RERE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 57.19
Fwd PE 7.95
RERE Price Earnings VS Forward Price EarningsRERE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RERE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.61
RERE Per share dataRERE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RERE's earnings are expected to grow with 372.58% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y372.58%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RERE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATRENEW INC

NYSE:RERE (9/25/2025, 11:21:09 AM)

4.575

-0.1 (-2.24%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-20 2025-08-20/bmo
Earnings (Next)11-18 2025-11-18
Inst Owners35.04%
Inst Owner Change-7.41%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.01B
Analysts85.71
Price Target5.1 (11.48%)
Short Float %2.21%
Short Ratio1.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)-0.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)1036.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.59%
Valuation
Industry RankSector Rank
PE 57.19
Fwd PE 7.95
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB 1.95
EV/EBITDA 18.61
EPS(TTM)0.08
EY1.75%
EPS(NY)0.58
Fwd EY12.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.97
BVpS2.37
TBVpS2.35
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.37%
ROE 3.39%
ROCE 3.8%
ROIC 3%
ROICexc 3%
ROICexgc 3.03%
OM 0.84%
PM (TTM) 0.73%
GM 11.97%
FCFM N/A
ROA(3y)-17.29%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y35.7%
F-ScoreN/A
Asset Turnover3.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.44
Altman-Z N/A
F-ScoreN/A
WACC8.38%
ROIC/WACC0.36
Cap/Depr(3y)21.03%
Cap/Depr(5y)18.67%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)164.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%269.23%
EPS Next Y1288.89%
EPS Next 2Y372.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.08%
Revenue growth 3Y28.03%
Revenue growth 5Y32.94%
Sales Q2Q%27.45%
Revenue Next Year28.47%
Revenue Next 2Y26.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y197.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y266.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.53%
OCF growth 3YN/A
OCF growth 5YN/A